Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals (INO) Stock Price & Analysis


INO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.55 - $2.82
Previous Close$0.58
Average Volume (3M)6.64M
Market Cap
Enterprise Value-$39.89M
Total Cash (Recent Filing)$223.75M
Total Debt (Recent Filing)$31.16M
Price to Earnings (P/E)-0.6
Aug 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.98
Shares Outstanding262,740,113
10 Day Avg. Volume9,250,032
30 Day Avg. Volume6,644,166
Standard Deviation0.26
Financial Highlights & Ratios
Price to Book (P/B)0.74
Price to Sales (P/S)1328.52
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-3.92
Enterprise Value/Gross Profit-3.89
Enterprise Value/Ebitda0.17
Price Target Upside244.12% Upside
Rating ConsensusHold
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Inovio Pharmaceuticals’s price range in the past 12 months?
Inovio Pharmaceuticals lowest stock price was $0.55 and its highest was $2.82 in the past 12 months.
    What is Inovio Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Inovio Pharmaceuticals’s upcoming earnings report date?
    Inovio Pharmaceuticals’s upcoming earnings report date is Aug 08, 2023 which is in 61 days.
      How were Inovio Pharmaceuticals’s earnings last quarter?
      Inovio Pharmaceuticals released its earnings results on May 10, 2023. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of -$0.145 by -$0.015.
        Is Inovio Pharmaceuticals overvalued?
        According to Wall Street analysts Inovio Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Inovio Pharmaceuticals pay dividends?
          Inovio Pharmaceuticals does not currently pay dividends.
          What is Inovio Pharmaceuticals’s EPS estimate?
          Inovio Pharmaceuticals’s EPS estimate is -$0.15.
            How many shares outstanding does Inovio Pharmaceuticals have?
            Inovio Pharmaceuticals has 262,740,100 shares outstanding.
              What happened to Inovio Pharmaceuticals’s price movement after its last earnings report?
              Inovio Pharmaceuticals reported an EPS of -$0.16 in its last earnings report, missing expectations of -$0.145. Following the earnings report the stock price went down -3.704%.
                Which hedge fund is a major shareholder of Inovio Pharmaceuticals?
                Among the largest hedge funds holding Inovio Pharmaceuticals’s share is Caxton Associates LP. It holds Inovio Pharmaceuticals’s shares valued at 643K.


                  Inovio Pharmaceuticals Stock Smart Score

                  The Inovio Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Inovio Pharmaceuticals

                  Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.


                  Top 5 ETFs holding INO

                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  Fidelity Nasdaq Composite Index ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Invesco Nasdaq Biotechnology ETF
                  Up to five ETFs with an Outperform Smart Score that hold INO. The ETFs are listed according to market value of INO within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Vir Biotechnology
                  BioNTech SE

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis